Stock Analysis

China Jo-Jo Drugstores Chairman & CEO Acquires 516% More Stock

Published
NasdaqCM:CJJD

Those following along with China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) will no doubt be intrigued by the recent purchase of shares by Lei Liu, Chairman & CEO of the company, who spent a stonking US$4.7m on stock at an average price of US$1.87. That purchase boosted their holding by 516%, which makes us wonder if the move was inspired by quietly confident deeply-felt optimism.

See our latest analysis for China Jo-Jo Drugstores

The Last 12 Months Of Insider Transactions At China Jo-Jo Drugstores

Notably, that recent purchase by Lei Liu is the biggest insider purchase of China Jo-Jo Drugstores shares that we've seen in the last year. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$1.51). Their view may have changed since then, but at least it shows they felt optimistic at the time. To us, it's very important to consider the price insiders pay for shares. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. Lei Liu was the only individual insider to buy during the last year.

The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

NasdaqCM:CJJD Insider Trading Volume September 7th 2024

There are always plenty of stocks that insiders are buying. If investing in lesser known companies is your style, you could take a look at this free list of companies. (Hint: insiders have been buying them).

Insider Ownership Of China Jo-Jo Drugstores

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It's great to see that China Jo-Jo Drugstores insiders own 45% of the company, worth about US$4.5m. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

What Might The Insider Transactions At China Jo-Jo Drugstores Tell Us?

It's certainly positive to see the recent insider purchase. And the longer term insider transactions also give us confidence. But we don't feel the same about the fact the company is making losses. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about China Jo-Jo Drugstores. Nice! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing China Jo-Jo Drugstores. Be aware that China Jo-Jo Drugstores is showing 4 warning signs in our investment analysis, and 2 of those make us uncomfortable...

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.